Page last updated: 2024-08-24

lamivudine and Cross Infection

lamivudine has been researched along with Cross Infection in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Figueiredo, FF; Gomes, SA; Lago, BV; Mello, FC; Motta, JS; Perez, RM1
Bunnapradist, S; Fabrizi, F; Martin, P1
Duan, XZ; Li, HW; Wang, FS; Wang, M; Xu, D; Zhuang, H1
Harada, S; Kaku, M; Koike, K; Mizokami, M; Oka, S1
Balducci, M; Clementi, M; Manzin, A; Petrelli, E; Pieretti, C; Rocchi, MB1

Reviews

1 review(s) available for lamivudine and Cross Infection

ArticleYear
HBV infection in patients with end-stage renal disease.
    Seminars in liver disease, 2004, Volume: 24 Suppl 1

    Topics: Antiviral Agents; Comorbidity; Cross Infection; Glomerulonephritis; Hepatitis B; Humans; Interferon-alpha; Kidney Failure, Chronic; Kidney Transplantation; Lamivudine; Renal Dialysis; Universal Precautions; Vaccination

2004

Other Studies

4 other study(ies) available for lamivudine and Cross Infection

ArticleYear
Occult hepatitis B virus infection and lamivudine-resistant mutations in isolates from renal patients undergoing hemodialysis.
    Journal of gastroenterology and hepatology, 2010, Volume: 25, Issue:1

    Topics: Adult; Aged; Antiviral Agents; Brazil; Cross Infection; DNA, Viral; Drug Resistance, Viral; Female; Gene Products, pol; Genotype; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C Antibodies; Humans; Lamivudine; Male; Middle Aged; Molecular Sequence Data; Mutation; Polymerase Chain Reaction; Prevalence; Renal Dialysis; Viral Envelope Proteins

2010
Decreased frequency and function of circulating plasmocytoid dendritic cells (pDC) in hepatitis B virus infected humans.
    Journal of clinical immunology, 2004, Volume: 24, Issue:6

    Topics: Adult; Blood Cell Count; Case-Control Studies; CD8-Positive T-Lymphocytes; Cross Infection; Dendritic Cells; Female; Hepatitis B; Humans; Immunity, Innate; Immunocompromised Host; Interferon-alpha; Killer Cells, Natural; Lamivudine; Leukocytes, Mononuclear; Liver Cirrhosis; Male; Middle Aged; Virus Replication

2004
[Diagnosis and therapy for attention-getting infections (discussion)].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2007, Nov-10, Volume: 96, Issue:11

    Topics: Antiretroviral Therapy, Highly Active; Antiviral Agents; Cause of Death; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Drug Resistance, Viral; Global Health; Hepatitis B; HIV Infections; Humans; Japan; Lamivudine; Measles; Practice Guidelines as Topic; Pseudomonas Infections; Reverse Transcriptase Inhibitors; Viral Vaccines

2007
Lamivudine treatment failure in preventing fatal outcome of de novo severe acute hepatitis B in patients with haematological diseases.
    Journal of hepatology, 2001, Volume: 35, Issue:6

    Topics: Acute Disease; Adult; Aged; Child; Cross Infection; Disease Outbreaks; Fatal Outcome; Female; Hematologic Diseases; Hepatitis B; Humans; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Treatment Failure

2001